This is a table of type proper and their frequencies. Use it to search & browse the list to learn more about your study carrel.
| proper | frequency |
|---|---|
| HIV | 5085 |
| AIDS | 3550 |
| China | 862 |
| der | 769 |
| Health | 659 |
| CD4 | 509 |
| United | 453 |
| SARS | 443 |
| HIV-1 | 438 |
| von | 407 |
| T | 347 |
| Africa | 337 |
| TB | 332 |
| Global | 330 |
| States | 328 |
| mit | 325 |
| bei | 306 |
| World | 286 |
| und | 262 |
| NGOs | 256 |
| werden | 241 |
| eine | 236 |
| CMV | 223 |
| US | 212 |
| Fund | 199 |
| HAART | 193 |
| C | 191 |
| sind | 187 |
| New | 181 |
| durch | 175 |
| den | 174 |
| CDC | 169 |
| zu | 167 |
| PCP | 165 |
| Therapie | 162 |
| ist | 159 |
| fi | 152 |
| einer | 150 |
| B | 147 |
| des | 143 |
| auch | 141 |
| South | 141 |
| PTG | 141 |
| National | 140 |
| Disease | 140 |
| International | 138 |
| Asia | 137 |
| auf | 137 |
| sich | 134 |
| Infektion | 134 |
| Kaposi | 133 |
| • | 127 |
| Canada | 127 |
| oder | 126 |
| fl | 126 |
| Prevention | 124 |
| Bank | 122 |
| zur | 121 |
| Fig | 120 |
| nicht | 116 |
| nach | 114 |
| UNAIDS | 114 |
| Human | 113 |
| America | 113 |
| India | 112 |
| A | 111 |
| KS | 110 |
| Group | 109 |
| C. | 108 |
| Organization | 107 |
| Public | 106 |
| Pneumocystis | 106 |
| mg | 104 |
| M. | 104 |
| Bei | 104 |
| das | 102 |
| Epi | 99 |
| B. | 99 |
| Control | 98 |
| Infektionen | 96 |
| Mycobacterium | 95 |
| Table | 95 |
| kann | 93 |
| Toronto | 93 |
| wird | 89 |
| WHO | 89 |
| RNA | 89 |
| Nations | 89 |
| BCG | 89 |
| COVID-19 | 88 |
| Development | 88 |
| Patienten | 88 |
| HCV | 87 |
| aus | 86 |
| York | 86 |
| Care | 86 |
| ARV | 86 |
| es | 85 |
| Treatment | 85 |
| II | 84 |
| City | 84 |
| Diseases | 83 |
| ein | 83 |
| Study | 81 |
| MSM | 81 |
| HIV/ | 81 |
| West | 79 |
| Ebola | 78 |
| Ministry | 77 |
| ciency | 76 |
| TNF | 76 |
| Aids | 75 |
| CT | 75 |
| Cryptococcus | 75 |
| UN | 74 |
| IRIS | 74 |
| Community | 73 |
| vor | 72 |
| infi | 72 |
| aber | 72 |
| Program | 72 |
| Europe | 71 |
| Foundation | 71 |
| als | 71 |
| dem | 71 |
| z. | 69 |
| Rights | 69 |
| können | 68 |
| NGO | 68 |
| Institute | 66 |
| Infectious | 66 |
| dass | 62 |
| Security | 62 |
| CD8 | 62 |
| General | 61 |
| sha | 60 |
| FIV | 60 |
| ~ | 59 |
| State | 59 |
| P. | 58 |
| Medicine | 58 |
| DNA | 58 |
| Center | 58 |
| SIV | 57 |
| Research | 57 |
| DOI | 57 |
| Council | 56 |
| Candida | 56 |
| nur | 56 |
| zum | 56 |
| le | 55 |
| SADC | 55 |
| S. | 55 |
| PCR | 55 |
| Erkrankungen | 55 |
| Department | 55 |
| Malaria | 54 |
| North | 54 |
| sehr | 53 |
| HSV | 53 |
| meist | 52 |
| gp120 | 52 |
| Thailand | 52 |
| President | 52 |
| Hospital | 52 |
| Das | 51 |
| Centre | 51 |
| Diagnostik | 51 |
| SSA | 51 |
| ne | 50 |
| confi | 50 |
| PEPFAR | 50 |
| Hepatitis | 50 |
| Beijing | 50 |
| les | 49 |
| Virus | 49 |
| Eine | 49 |
| U.S. | 48 |
| FDA | 48 |
| chez | 48 |
| Initiative | 47 |
| Cohen | 47 |
| Symptome | 47 |
| gegen | 46 |
| Tuberculosis | 46 |
| Saharan | 46 |
| SMX | 46 |
| HBV | 46 |
| Declaration | 46 |
| › | 45 |
| HHV-8 | 44 |
| Aid | 44 |
| kommt | 44 |
| Services | 44 |
| einem | 44 |
| sie | 43 |
| immunodefi | 43 |
| hepatitis | 43 |
| T4 | 43 |
| Der | 43 |
| Chap | 42 |
| Centers | 42 |
| Erkrankung | 42 |
| Singapore | 42 |
| _ | 42 |
| IMF | 42 |
| Central | 41 |
| Zellen | 41 |
| XDR | 41 |
| Nachweis | 41 |
| MAC | 41 |
| Interviewee | 41 |
| IFN | 41 |
| Clinical | 41 |
| CSF | 41 |
| Medical | 40 |
| D | 40 |
| East | 40 |
| I | 40 |
| Uganda | 40 |
| NTM | 40 |
| PLHIV | 40 |
| USA | 40 |
| Es | 39 |
| Social | 39 |
| Erreger | 39 |
| Americans | 39 |
| Report | 39 |
| Vancouver | 39 |
| Substanzen | 39 |
| defi | 39 |
| TMP | 39 |
| jirovecii | 39 |
| University | 39 |
| GI | 38 |
| ELISA | 38 |
| IOM | 38 |
| sein | 37 |
| kg | 37 |
| für | 37 |
| People | 37 |
| Evaluation | 37 |
| Committee | 37 |
| Association | 36 |
| H. | 36 |
| August | 36 |
| Director | 36 |
| Kingdom | 36 |
| itraconazole | 36 |
| keine | 36 |
| Society | 36 |
| San | 35 |
| African | 35 |
| IL-6 | 34 |
| American | 34 |
| E. | 34 |
| Republic | 34 |
| anderen | 34 |
| häufig | 34 |
| Women | 33 |
| May | 33 |
| March | 33 |
| January | 33 |
| HTLV | 33 |
| Drug | 33 |
| Chinese | 33 |
| Les | 32 |
| Zhao | 32 |
| IL-1 | 32 |
| Nile | 32 |
| Network | 32 |
| meta | 32 |
| USD | 32 |
| diffi | 32 |
| bis | 32 |
| über | 31 |
| möglich | 31 |
| Viren | 31 |
| Rhodococcus | 31 |
| Mexico | 31 |
| Japan | 31 |
| Hong | 31 |
| Cytomegalovirus | 31 |
| Union | 30 |
| Jahren | 30 |
| MHC | 30 |
| Ping | 30 |
| Food | 30 |
| War | 30 |
| comm | 30 |
| gibt | 30 |
| neoformans | 30 |
| Botswana | 29 |
| CA | 29 |
| CNS | 29 |
| Francisco | 29 |
| Haven | 29 |
| July | 29 |
| Le | 29 |
| Lee | 29 |
| Li | 29 |
| Menschen | 29 |
| Project | 29 |
| Science | 29 |
| pers | 29 |
| wie | 29 |
| Australia | 28 |
| Gates | 28 |
| Impfung | 28 |
| HPV | 28 |
| Guidelines | 28 |
| Latin | 28 |
| führt | 28 |
| gattii | 28 |
| Policy | 28 |
| Nach | 27 |
| Act | 27 |
| Analysis | 27 |
| Assembly | 27 |
| Ata | 27 |
| Diese | 27 |
| E | 27 |
| J. | 27 |
| M | 27 |
| Alma | 27 |
| October | 27 |
| Working | 27 |
| bzw | 27 |
| est | 27 |
| kommen | 27 |
| mm | 27 |
| muss | 27 |
| sida | 27 |
| Urban | 27 |
| EBV | 26 |
| < | 26 |
| Autonomy | 26 |
| Bill | 26 |
| Columbia | 26 |
| December | 26 |
| Die | 26 |
| June | 26 |
| Family | 26 |
| Fieber | 26 |
| Kong | 26 |
| Mumbai | 26 |
| dann | 26 |
| müssen | 26 |
| un | 26 |
| Bedeutung | 25 |
| Life | 25 |
| J | 25 |
| Emerging | 25 |
| Nabs | 25 |
| BSE | 25 |
| Atlan | 25 |
| Action | 25 |
| Access | 25 |
| Management | 25 |
| ou | 25 |
| SP | 25 |
| Sie | 25 |
| St. | 25 |
| Verlauf | 25 |
| allem | 25 |
| du | 25 |
| herpes | 25 |
| immunode | 25 |
| Service | 25 |
| Funding | 24 |
| November | 24 |
| Killmister | 24 |
| Kenya | 24 |
| Jakob | 24 |
| Jahre | 24 |
| Blut | 24 |
| Chemotherapie | 24 |
| British | 24 |
| Box | 24 |
| Office | 24 |
| Administration | 24 |
| OPV | 24 |
| Ontario | 24 |
| simplex | 24 |
| S | 24 |
| dieser | 24 |
| eines | 24 |
| führen | 24 |
| infl | 24 |
| nan | 24 |
| noch | 24 |
| R | 24 |
| une | 24 |
| · | 24 |
| α | 24 |
| CoV-2 | 23 |
| Epidemic | 23 |
| EIS | 23 |
| L. | 23 |
| Clinton | 23 |
| Behandlung | 23 |
| Ghana | 23 |
| PPD | 23 |
| PML | 23 |
| Survey | 23 |
| UK | 23 |
| alle | 23 |
| einen | 23 |
| klinischen | 23 |
| Trials | 22 |
| Advisory | 22 |
| AmBd | 22 |
| Creutzfeldt | 22 |
| Herpes | 22 |
| IDU | 22 |
| Mele | 22 |
| NYC | 22 |
| Risk | 22 |
| Plan | 22 |
| Turkey | 22 |
| beim | 22 |
| Use | 22 |
| s. | 22 |
| haben | 22 |
| ed | 22 |
| wurde | 22 |
| au | 22 |
| aky | 22 |
| Wochen | 22 |
| Lithuania | 21 |
| April | 21 |
| Brazil | 21 |
| California | 21 |
| Court | 21 |
| GBD | 21 |
| Germany | 21 |
| Impact | 21 |
| Information | 21 |
| Intelligence | 21 |
| La | 21 |
| Nigeria | 21 |
| MAI | 21 |
| Syndrome | 21 |
| die | 21 |
| Y | 21 |
| Vpr | 21 |
| Taiwan | 21 |
| selten | 21 |
| Programme | 21 |
| Primary | 21 |
| Pacific | 21 |
| PDH | 21 |
| Oshana | 20 |
| Board | 20 |
| CTL | 20 |
| Caputo | 20 |
| Christman | 20 |
| Emergency | 20 |
| Framework | 20 |
| France | 20 |
| Gabe | 20 |
| Joseph | 20 |
| Law | 20 |
| MOH | 20 |
| Regulations | 20 |
| Pneumothorax | 20 |
| enteropathy | 20 |
| unter | 20 |
| sont | 20 |
| ned | 20 |
| heute | 20 |
| schweren | 20 |
| daher | 20 |
| besteht | 20 |
| VZV | 20 |
| School | 20 |
| Rolle | 20 |
| Indonesia | 19 |
| Antikörper | 19 |
| Canadian | 19 |
| Cohort | 19 |
| Economic | 19 |
| F | 19 |
| Government | 19 |
| III | 19 |
| IPV | 19 |
| September | 19 |
| Lassa | 19 |
| Paris | 19 |
| Population | 19 |
| Ravven | 19 |
| Salmonella | 19 |
| Staphylococcus | 19 |
| fluconazole | 19 |
| MDM2 | 19 |
| wenn | 19 |
| IHR | 18 |
| HLA | 18 |
| House | 18 |
| MDRTB | 18 |
| Institutes | 18 |
| Joint | 18 |
| Lu | 18 |
| Gaylin | 18 |
| MMR | 18 |
| Geneva | 18 |
| CCR5 | 18 |
| Fällen | 18 |
| Dr. | 18 |
| CJD | 18 |
| Business | 18 |
| Black | 18 |
| Auftreten | 18 |
| Antibiotika | 18 |
| Als | 18 |
| Agency | 18 |
| Abb | 18 |
| Merck | 18 |
| Melinda | 18 |
| Hodgkin | 18 |
| Minister | 18 |
| Zhang | 18 |
| O'Brien | 18 |
| zwischen | 18 |
| mehr | 18 |
| lassen | 18 |
| jedoch | 18 |
| immer | 18 |
| ganciclovir | 18 |
| dans | 18 |
| ca | 18 |
| bronchoalveolar | 18 |
| klinisch | 18 |
| Wu | 18 |
| Southeast | 18 |
| Vaccine | 18 |
| P4 | 18 |
| Pneumokokken | 18 |
| STD | 18 |
| Review | 18 |
| Southern | 18 |
| Surveillance | 18 |
| System | 18 |
| Untersuchung | 18 |
| MTCT | 17 |
| Durch | 17 |
| Lyapunov | 17 |
| LAS | 17 |
| Influenza | 17 |
| ID | 17 |
| High | 17 |
| CCM | 17 |
| Death | 17 |
| David | 17 |
| Coronavirus | 17 |
| Commission | 17 |
| Campylobacter | 17 |
| Blood | 17 |
| NIH | 17 |
| Middle | 17 |
| Street | 17 |
| PSP | 17 |
| deren | 17 |
| Übertragung | 17 |
| zunächst | 17 |
| vivo | 17 |
| sulfamethoxazole | 17 |
| ob | 17 |
| evtl | 17 |
| treten | 17 |
| Youth | 17 |
| Veränderungen | 17 |
| Tian | 17 |
| Tage | 17 |
| Therapy | 17 |
| Tanzania | 17 |
| Washington | 17 |
| Prognose | 16 |
| John | 16 |
| Maßnahmen | 16 |
| PDN | 16 |
| Response | 16 |
| Protection | 16 |
| R. | 16 |
| Richard | 16 |
| Immunization | 16 |
| Infizierten | 16 |
| Connecticut | 16 |
| Histoplasma | 16 |
| HPA | 16 |
| HIV-2 | 16 |
| HIV+ | 16 |
| Für | 16 |
| Eastern | 16 |
| Second | 16 |
| Coalition | 16 |
| Bush | 16 |
| Americas | 16 |
| Safety | 16 |
| Inner | 16 |
| Smith | 16 |
| denen | 16 |
| Systems | 16 |
| traffi | 16 |
| pentamidine | 16 |
| klinische | 16 |
| kaposi | 16 |
| hydroxychloroquine | 16 |
| hoher | 16 |
| erfolgt | 16 |
| erfolgen | 16 |
| u. | 16 |
| cytomegalovirus | 16 |
| behandelt | 16 |
| Zahl | 16 |
| Yunnan | 16 |
| YNHH | 16 |
| Xiao | 16 |
| White | 16 |
| Western | 16 |
| bekannt | 16 |
| Watch | 16 |
| Goals | 15 |
| GBC | 15 |
| Giardia | 15 |
| Impfstoff | 15 |
| H5N1 | 15 |
| Hemmung | 15 |
| Immune | 15 |
| Felidae | 15 |
| Forward | 15 |
| Bureau | 15 |
| FDC | 15 |
| European | 15 |
| Epstein | 15 |
| Deutschland | 15 |
| Antiretroviral | 15 |
| Angeles | 15 |
| Alcohol | 15 |
| Aedes | 15 |
| A. | 15 |
| Los | 15 |
| London | 15 |
| HVR2 | 15 |
| Mozambique | 15 |
| Young | 15 |
| N | 15 |
| worden | 15 |
| ltrative | 15 |
| immunodeficiency | 15 |
| ethambutol | 15 |
| disease | 15 |
| da | 15 |
| ammatory | 15 |
| allen | 15 |
| ltration | 15 |
| Way | 15 |
| Prionen | 15 |
| Nairobi | 15 |
| Virusvermehrung | 15 |
| PRC | 15 |
| Philadelphia | 15 |
| Puerto | 15 |
| SES | 15 |
| Sub | 15 |
| Threats | 15 |
| ER | 14 |
| I. | 14 |
| Education | 14 |
| February | 14 |
| HVR5 | 14 |
| Healthcare | 14 |
| Histoplasmosis | 14 |
| Introduction | 14 |
| ICU | 14 |
| IgM | 14 |
| Infections | 14 |
| Isospora | 14 |
| Local | 14 |
| Microsporidia | 14 |
| Crittenden | 14 |
| Cryptococcal | 14 |
| Alliance | 14 |
| Cl | 14 |
| Children | 14 |
| Child | 14 |
| CVD | 14 |
| CC | 14 |
| CBP | 14 |
| Biological | 14 |
| Barr | 14 |
| BC | 14 |
| BAL | 14 |
| Affairs | 14 |
| Ad5 | 14 |
| ARDS | 14 |
| 8) | 14 |
| Model | 14 |
| Millennium | 14 |
| trimethoprim | 14 |
| Monate | 14 |
| handelt | 14 |
| Zur | 14 |
| ammation | 14 |
| andere | 14 |
| che | 14 |
| culty | 14 |
| diese | 14 |
| immunocompromis | 14 |
| ZNS | 14 |
| marneffei | 14 |
| p300 | 14 |
| schwer | 14 |
| seit | 14 |
| sollte | 14 |
| NC | 14 |
| Zambia | 14 |
| gancyclovir | 14 |
| Untersuchungen | 14 |
| Practice | 14 |
| UNICEF | 14 |
| Neben | 14 |
| Nebenwirkungen | 14 |
| ORT | 14 |
| PLWH | 14 |
| Philippines | 14 |
| Park | 14 |
| Premier | 14 |
| Respiratory | 14 |
| Serengeti | 14 |
| Shigella | 14 |
| Tab | 14 |
| Times | 14 |
| G | 13 |
| IV | 13 |
| Guangdong | 13 |
| HTLV-1 | 13 |
| Haut | 13 |
| Helicobacter | 13 |
| Herpesviren | 13 |
| IDUs | 13 |
| NIAID | 13 |
| Itraconazole | 13 |
| Kap | 13 |
| Kindern | 13 |
| Kuhn | 13 |
| Lymphozyten | 13 |
| MDR | 13 |
| Fluconazole | 13 |
| Fraulino | 13 |
| ARC | 13 |
| Erwachsenen | 13 |
| Enterocytozoon | 13 |
| News | 13 |
| Adams | 13 |
| Amsterdam | 13 |
| Anderson | 13 |
| BP | 13 |
| Bild | 13 |
| CRH | 13 |
| Chloroquine | 13 |
| Corporation | 13 |
| Dengue | 13 |
| Document | 13 |
| EG2 | 13 |
| EISOs | 13 |
| Effect | 13 |
| Ein | 13 |
| Nationalism | 13 |
| Med | 13 |
| Non | 13 |
| letzten | 13 |
| azithromycin | 13 |
| bereits | 13 |
| damit | 13 |
| doc_id | 13 |
| einigen | 13 |
| ersten | 13 |
| hier | 13 |
| leukoencephalopathy | 13 |
| acyclovir | 13 |
| muqueuse | 13 |
| orale | 13 |
| pyrimethamine | 13 |
| schon | 13 |
| verschiedene | 13 |
| weltweit | 13 |
| Nukleosidanaloga | 13 |
| auranofin | 13 |
| etwa | 13 |
| ab | 13 |
| Risiko | 13 |
| Vice | 13 |
| OI | 13 |
| Pandemic | 13 |
| Pediatric | 13 |
| Politics | 13 |
| RT | 13 |
| Relief | 13 |
| Nursing | 13 |
| Secretary | 13 |
| Soviet | 13 |
| Supreme | 13 |
| Tagen | 13 |
| Team | 13 |
| Thalidomide | 13 |
| UNSC | 13 |
| Italy | 12 |
| G. | 12 |
| Ganciclovir | 12 |
| George | 12 |
| Healthy | 12 |
| Immunodeficiency | 12 |
| Impfungen | 12 |
| Interferon | 12 |
| Interferone | 12 |
| Journal | 12 |
| Jahr | 12 |
| Jennings | 12 |
| Figure | 12 |
| Kinder | 12 |
| Lancet | 12 |
| Lyme | 12 |
| Mensch | 12 |
| ND | 12 |
| Four | 12 |
| ANG | 12 |
| Executive | 12 |
| Definition | 12 |
| Pakistan | 12 |
| Ad | 12 |
| Agents | 12 |
| Allergy | 12 |
| BY | 12 |
| Bangladesh | 12 |
| Bashforth | 12 |
| Beschwerden | 12 |
| Burden | 12 |
| CVLP | 12 |
| Century | 12 |
| CoV | 12 |
| Cocoa360 | 12 |
| Conference | 12 |
| Countries | 12 |
| D. | 12 |
| DS | 12 |
| Ottawa | 12 |
| Ethics | 12 |
| Pathogenese | 12 |
| während | 12 |
| dar | 12 |
| ebenfalls | 12 |
| einige | 12 |
| elds | 12 |
| foscarnet | 12 |
| gp41 | 12 |
| infizierten | 12 |
| intracellulare | 12 |
| niveau | 12 |
| odynophagia | 12 |
| signifi | 12 |
| social | 12 |
| spezifische | 12 |
| stehen | 12 |
| stellt | 12 |
| weitere | 12 |
| Patient | 12 |
| classifi | 12 |
| liegt | 12 |
| aux | 12 |
| STI | 12 |
| Plague | 12 |
| antiviralen | 12 |
| Pneumonie | 12 |
| Programs | 12 |
| Resistenz | 12 |
| Russia | 12 |
| Rwanda | 12 |
| SHIV | 12 |
| Rico | 12 |
| Zaire | 12 |
| Studien | 12 |
| Studies | 12 |
| TAA | 12 |
| Tat | 12 |
| Veterans | 12 |
| Spezies | 12 |
| Weapons | 12 |
| Erregernachweis | 11 |
| Giemsa | 11 |
| Gesundheit | 11 |
| Gegensatz | 11 |
| GHI | 11 |
| First | 11 |
| Foreign | 11 |
| Folge | 11 |
| Exchange | 11 |
| HCPs | 11 |
| Guidance | 11 |
| Legionella | 11 |
| IgG | 11 |
| Immunsupprimierten | 11 |
| Infection | 11 |
| Inkubationszeit | 11 |
| Island | 11 |
| Kombination | 11 |
| Kombinationstherapie | 11 |
| Lesotho | 11 |
| Liquor | 11 |
| Efficacy | 11 |
| Entamoeba | 11 |
| Anwendung | 11 |
| EG1 | 11 |
| EAE | 11 |
| AMB | 11 |
| Academy | 11 |
| Agenda | 11 |
| Amphotericin | 11 |
| Meeting | 11 |
| Appendix | 11 |
| Auch | 11 |
| Building | 11 |
| CHAI | 11 |
| CHF | 11 |
| COPD | 11 |
| CSW | 11 |
| Calhoun | 11 |
| Caribbean | 11 |
| Chlamydia | 11 |
| Civil | 11 |
| Coccidioidomycosis | 11 |
| County | 11 |
| Cuba | 11 |
| DPT | 11 |
| Data | 11 |
| MVA | 11 |
| Koch | 11 |
| Moulton | 11 |
| Verfügung | 11 |
| Vietnam | 11 |
| Zell | 11 |
| antiretroviralen | 11 |
| beobachtet | 11 |
| d'une | 11 |
| diesen | 11 |
| finden | 11 |
| i.v | 11 |
| innerhalb | 11 |
| los | 11 |
| nachgewiesen | 11 |
| ohne | 11 |
| peut | 11 |
| pneumocystosis | 11 |
| ro | 11 |
| sondern | 11 |
| spezifischen | 11 |
| verschiedenen | 11 |
| vom | 11 |
| wenig | 11 |
| Mycoses | 11 |
| Viele | 11 |
| mehrere | 11 |
| VCT | 11 |
| Resolution | 11 |
| Nation | 11 |
| Universal | 11 |
| Nutrition | 11 |
| OECD | 11 |
| PH+ | 11 |
| PLWHA | 11 |
| Penicillin | 11 |
| Picornaviren | 11 |
| Proteine | 11 |
| Regel | 11 |
| Phase | 11 |
| Tuberkulose | 11 |
| Sex | 11 |
| Special | 11 |
| Stoljar | 11 |
| Stuhl | 11 |
| Syndrom | 11 |
| TAH | 11 |
| Trade | 11 |
| Scarborough | 11 |
| Type | 11 |
| Integration | 10 |
| Ländern | 10 |
| Lederberg | 10 |
| Jones | 10 |
| JC | 10 |
| ICP | 10 |
| Infektionskrankheiten | 10 |
| Piot | 10 |
| Index | 10 |
| Immigration | 10 |
| Manhattan | 10 |
| Makrophagen | 10 |
| PTX | 10 |
| Mann | 10 |
| Michael | 10 |
| Milam | 10 |
| Milwaukee | 10 |
| Mortality | 10 |
| NANBH | 10 |
| Nepal | 10 |
| Nipah | 10 |
| Note | 10 |
| PTSD | 10 |
| Paget | 10 |
| H | 10 |
| HIVpositive | 10 |
| Adenovirus | 10 |
| Frees | 10 |
| Form | 10 |
| AA | 10 |
| ACE2 | 10 |
| Allen | 10 |
| Anti | 10 |
| Assessment | 10 |
| Atlanta | 10 |
| Bakterien | 10 |
| Blastomycosis | 10 |
| Blutkultur | 10 |
| CG | 10 |
| Case | 10 |
| Castro | 10 |
| Chicago | 10 |
| Cidofovir | 10 |
| Clinic | 10 |
| Congress | 10 |
| DC | 10 |
| Detection | 10 |
| Elliot | 10 |
| England | 10 |
| Enzephalitis | 10 |
| Eradication | 10 |
| Fast | 10 |
| Pilze | 10 |
| WBC | 10 |
| Problem | 10 |
| ihre | 10 |
| effi | 10 |
| eher | 10 |
| equi | 10 |
| erforderlich | 10 |
| findet | 10 |
| fr6quemment | 10 |
| gelegentlich | 10 |
| ggf | 10 |
| habe | 10 |
| hexon | 10 |
| identifi | 10 |
| je | 10 |
| coccidioidomycosis | 10 |
| n= | 10 |
| nef | 10 |
| refl | 10 |
| syndrome | 10 |
| viele | 10 |
| wirksame | 10 |
| wurden | 10 |
| zeigt | 10 |
| × | 10 |
| σ | 10 |
| Progress | 10 |
| deutlich | 10 |
| sog | 10 |
| blastomycosis | 10 |
| Sustainable | 10 |
| Prophylaxe | 10 |
| akuten | 10 |
| Province | 10 |
| Quality | 10 |
| Robert | 10 |
| SIF | 10 |
| Shawn | 10 |
| Spektrum | 10 |
| Stability | 10 |
| Streptokokken | 10 |
| Substanz | 10 |
| Round | 10 |
| Sydney | 10 |
| Une | 10 |
| Woods | 10 |
| Technology | 10 |
| ZDV | 10 |
| Wirksamkeit | 10 |
| W. | 10 |
| Torres | 10 |
| Testing | 10 |
| Test | 10 |
| Tedeschi | 10 |
| Kiss | 9 |
| Hib | 9 |
| Israel | 9 |
| Indikationen | 9 |
| Kontakt | 9 |
| Immunsystems | 9 |
| Immunität | 9 |
| Immunantwort | 9 |
| HBM | 9 |
| Helms | 9 |
| Hamilton | 9 |
| Haiti | 9 |
| Great | 9 |
| Genotypen | 9 |
| GOARN | 9 |
| LA | 9 |
| Free | 9 |
| Krankheitsbild | 9 |
| Meta | 9 |
| LDH | 9 |
| Mental | 9 |
| Foscarnet | 9 |
| NPY | 9 |
| Möglichkeit | 9 |
| Mucosal | 9 |
| Montreal | 9 |
| Moleküle | 9 |
| Metrics | 9 |
| Meningokokken | 9 |
| Lawler | 9 |
| Marburg | 9 |
| Malaysia | 9 |
| MPER | 9 |
| MD | 9 |
| Linley | 9 |
| Lider | 9 |
| Level | 9 |
| Frankfurt | 9 |
| Carvalho | 9 |
| Forum | 9 |
| Bildung | 9 |
| Chen | 9 |
| Chemotherapeutika | 9 |
| Chang | 9 |
| Neisseria | 9 |
| Cancer | 9 |
| Calmette | 9 |
| CIA | 9 |
| Beginn | 9 |
| College | 9 |
| Bangalore | 9 |
| Art | 9 |
| Army | 9 |
| Antibiotikatherapie | 9 |
| Agent | 9 |
| ACWF | 9 |
| ACE | 9 |
| Chronic | 9 |
| Commitment | 9 |
| Farmer | 9 |
| EVD | 9 |
| Fall | 9 |
| Erregers | 9 |
| Erfolg | 9 |
| Epidemiology | 9 |
| Epidemiologie | 9 |
| Entstehung | 9 |
| Ende | 9 |
| EM | 9 |
| Comparative | 9 |
| EBM | 9 |
| Dying | 9 |
| Dworkin | 9 |
| DDT | 9 |
| Cryptosporidium | 9 |
| Country | 9 |
| Cook | 9 |
| Nature | 9 |
| MAP | 9 |
| Netherlands | 9 |
| hilum | 9 |
| meningoencephalitis | 9 |
| meisten | 9 |
| lässt | 9 |
| lymphocytopenia | 9 |
| lorsque | 9 |
| lang | 9 |
| i | 9 |
| hematoxylin | 9 |
| ont | 9 |
| health | 9 |
| erreichen | 9 |
| el | 9 |
| eSwatini | 9 |
| clarithromycin | 9 |
| bezeichnet | 9 |
| beiden | 9 |
| mycobacterial | 9 |
| p= | 9 |
| Yoon | 9 |
| uconazole | 9 |
| Ohio | 9 |
| ψ | 9 |
| wegen | 9 |
| viralen | 9 |
| villous | 9 |
| vielen | 9 |
| van | 9 |
| toxoplasmic | 9 |
| par | 9 |
| stercoralis | 9 |
| steht | 9 |
| spielen | 9 |
| sera | 9 |
| rst | 9 |
| rifabutin | 9 |
| pleuritis | 9 |
| azole | 9 |
| n.d | 9 |
| Won | 9 |
| SD | 9 |
| Rosenthal | 9 |
| Replikation | 9 |
| Regional | 9 |
| Region | 9 |
| Reduction | 9 |
| Pulmonary | 9 |
| Press | 9 |
| Pneumonien | 9 |
| Peter | 9 |
| Personen | 9 |
| Peace | 9 |
| Party | 9 |
| Pan | 9 |
| PMTCT | 9 |
| PEI | 9 |
| Wirkung | 9 |
| PACTG | 9 |
| S1 | 9 |
| Political | 9 |
| Wie | 9 |
| Troyer | 9 |
| William | 9 |
| SEI | 9 |
| Von | 9 |
| Viral | 9 |
| Verfahren | 9 |
| Typ | 9 |
| Trypanosoma | 9 |
| Valley | 9 |
| Transmission | 9 |
| Thai | 9 |
| Sung | 9 |
| Summary | 9 |
| Strategy | 9 |
| SOT | 9 |
| SNP309 | 9 |
| K. | 8 |
| Harvard | 8 |
| Johnson | 8 |
| JCV | 8 |
| Indikation | 8 |
| IL-12 | 8 |
| IDA | 8 |
| Hydroxychloroquine | 8 |
| Henan | 8 |
| Georgia | 8 |
| Hall | 8 |
| Haemophilus | 8 |
| HRCT | 8 |
| H7 | 8 |
| Gruppen | 8 |
| Gruppe | 8 |
| Green | 8 |
| Governance | 8 |
| Kaufman | 8 |
| Kampala | 8 |
| Nobel | 8 |
| Krankheit | 8 |
| Krankheiten | 8 |
| GBV | 8 |
| Norwalk | 8 |
| Neumann | 8 |
| Moore | 8 |
| Montagnier | 8 |
| Meningitis | 8 |
| Mediterranean | 8 |
| Medikamente | 8 |
| Mechanisms | 8 |
| Mathematical | 8 |
| Material | 8 |
| MDGs | 8 |
| Länder | 8 |
| Letalität | 8 |
| Leone | 8 |
| Laboratory | 8 |
| L | 8 |
| Gattung | 8 |
| Abstract | 8 |
| GALT | 8 |
| Communicable | 8 |
| Cochrane | 8 |
| Chemical | 8 |
| Centres | 8 |
| CI | 8 |
| Blutkulturen | 8 |
| Befunde | 8 |
| BTS | 8 |
| Azithromycin | 8 |
| Associated | 8 |
| Aspergillus | 8 |
| Asian | 8 |
| Antikörpernachweis | 8 |
| Antigen | 8 |
| Annual | 8 |
| Ag85 | 8 |
| ACV | 8 |
| O'Neill | 8 |
| Collaborative | 8 |
| Congo | 8 |
| Financing | 8 |
| Convention | 8 |
| Fidler | 8 |
| Familie | 8 |
| Factors | 8 |
| Erregern | 8 |
| English | 8 |
| El | 8 |
| Egypt | 8 |
| EPI | 8 |
| EIs | 8 |
| Dosis | 8 |
| Differentialdiagnose | 8 |
| Depression | 8 |
| Democratic | 8 |
| Daily | 8 |
| DFE | 8 |
| DAIG | 8 |
| Crisis | 8 |
| O | 8 |
| Roelke | 8 |
| OR= | 8 |
| lamblia | 8 |
| justice | 8 |
| gondii | 8 |
| gestellt | 8 |
| gegenüber | 8 |
| enterica | 8 |
| d.h | 8 |
| cryptosporidiosis | 8 |
| cruzi | 8 |
| capsulatum | 8 |
| c. | 8 |
| bieneusi | 8 |
| belli | 8 |
| auftreten | 8 |
| aufgrund | 8 |
| antivirale | 8 |
| aller | 8 |
| Zeit | 8 |
| konnte | 8 |
| nd | 8 |
| XMRV | 8 |
| neuen | 8 |
| OptAIDS | 8 |
| ~tre | 8 |
| ~n | 8 |
| ~e | 8 |
| | | 8 |
| wichtige | 8 |
| weiteren | 8 |
| waren | 8 |
| viel | 8 |
| var | 8 |
| vCJD | 8 |
| transthoracic | 8 |
| sowie | 8 |
| sogar | 8 |
| rhodococcus | 8 |
| rasch | 8 |
| pneumocystis | 8 |
| Yale | 8 |
| o. | 8 |
| Williams | 8 |
| Sputum | 8 |
| Sierra | 8 |
| Sharp | 8 |
| Shanghai | 8 |
| SHC | 8 |
| SCT | 8 |
| S2 | 8 |
| Rotary | 8 |
| β | 8 |
| Reaktivierung | 8 |
| Rapid | 8 |
| Rahmen | 8 |
| Pleural | 8 |
| Penicillium | 8 |
| Paul | 8 |
| PTHrP | 8 |
| PPE | 8 |
| Westlund | 8 |
| Solomon | 8 |
| Related | 8 |
| Standard | 8 |
| Threat | 8 |
| Wen | 8 |
| Stop | 8 |
| Welche | 8 |
| Wegen | 8 |
| WTCHR | 8 |
| W | 8 |
| ValACV | 8 |
| Toxoplasma | 8 |
| Verdacht | 8 |
| Tables | 8 |
| TSS | 8 |
| T3 | 8 |
| T. | 8 |
| Surgeon | 8 |
| Student | 8 |
| Taylor | 8 |
| Struktur | 8 |
| Korea | 7 |
| Isolation | 7 |
| Inc. | 7 |
| Incidence | 7 |
| Indians | 7 |
| Komplikationen | 7 |
| K | 7 |
| L'infection | 7 |
| Kikwit | 7 |
| Immunisierung | 7 |
| Immunsuppression | 7 |
| Harm | 7 |
| Immundefekten | 7 |
| IgA | 7 |
| INH | 7 |
| IM | 7 |
| IL-2 | 7 |
| IHME | 7 |
| IEU | 7 |
| Hu | 7 |
| HSV-2 | 7 |
| Lunge | 7 |
| HRV | 7 |
| Listeria | 7 |
| OIE | 7 |
| Lymphknoten | 7 |
| MHS | 7 |
| Greater | 7 |
| Organe | 7 |
| OP | 7 |
| OIs | 7 |
| Nicht | 7 |
| NR | 7 |
| N. | 7 |
| Murphy | 7 |
| Ms. | 7 |
| Mother | 7 |
| Mechanismen | 7 |
| Mechanism | 7 |
| Measles | 7 |
| Mbeki | 7 |
| Maßnahme | 7 |
| Mass | 7 |
| Masern | 7 |
| Martin | 7 |
| Marie | 7 |
| Mairuhu | 7 |
| MMT | 7 |
| HHV-6 | 7 |
| Atovaquone | 7 |
| Gao | 7 |
| Baltimore | 7 |
| CUP | 7 |
| CHC | 7 |
| CDV | 7 |
| CBR | 7 |
| Besserung | 7 |
| Bereich | 7 |
| Beispiel | 7 |
| Beim | 7 |
| Based | 7 |
| Bartonella | 7 |
| Background | 7 |
| G8 | 7 |
| Au | 7 |
| Outbreak | 7 |
| Assistant | 7 |
| Arizona | 7 |
| Anthony | 7 |
| Aminosäuren | 7 |
| AZT | 7 |
| ATS | 7 |
| ATL | 7 |
| ACT | 7 |
| Carpenter | 7 |
| Census | 7 |
| Chagas | 7 |
| Chest | 7 |
| Fälle | 7 |
| Frage | 7 |
| Field | 7 |
| Fever | 7 |
| Fauci | 7 |
| FP | 7 |
| Evolution | 7 |
| Escherichia | 7 |
| Env | 7 |
| Empfehlungen | 7 |
| Effectiveness | 7 |
| Durchmesser | 7 |
| Dosierung | 7 |
| District | 7 |
| Darm | 7 |
| Da | 7 |
| Cryptococcosis | 7 |
| Cross | 7 |
| Complications | 7 |
| Cold | 7 |
| Clark | 7 |
| Organizations | 7 |
| Liposomal | 7 |
| PHC | 7 |
| diarrh6es | 7 |
| histolytica | 7 |
| histologique | 7 |
| hatte | 7 |
| großen | 7 |
| frühen | 7 |
| ferner | 7 |
| erst | 7 |
| enterocyte | 7 |
| en | 7 |
| efavirenz | 7 |
| cryptococcosis | 7 |
| infektiösen | 7 |
| crofelemer | 7 |
| count | 7 |
| cidofovir | 7 |
| chronische | 7 |
| bislang | 7 |
| bisher | 7 |
| biopsy | 7 |
| bilden | 7 |
| beschrieben | 7 |
| antiretrovirale | 7 |
| immunsupprimierten | 7 |
| intestinale | 7 |
| Zimbabwe | 7 |
| spielt | 7 |
| PLWA | 7 |
| λ | 7 |
| || | 7 |
| zusammen | 7 |
| wieder | 7 |
| wichtigsten | 7 |
| vollständig | 7 |
| verursachen | 7 |
| trotz | 7 |
| später | 7 |
| sinnvoll | 7 |
| intestinalis | 7 |
| sei | 7 |
| scheint | 7 |
| puma | 7 |
| pentoxifylline | 7 |
| möglichst | 7 |
| microsporidia | 7 |
| mRNA | 7 |
| lymphotropic | 7 |
| lymphadenectasis | 7 |
| leicht | 7 |
| allerdings | 7 |
| mass | 7 |
| Zelle | 7 |
| Qian | 7 |
| STIKO | 7 |
| SPHC | 7 |
| SESSIONS | 7 |
| SDI | 7 |
| S3 | 7 |
| Retinomax | 7 |
| Relations | 7 |
| RTI | 7 |
| REE | 7 |
| RBG | 7 |
| PubMed | 7 |
| Schleimhaut | 7 |
| Promotion | 7 |
| Products | 7 |
| Principles | 7 |
| Peoples | 7 |
| Pennsylvania | 7 |
| Pediatrics | 7 |
| Partnership | 7 |
| Papanicolau | 7 |
| Xuedong | 7 |
| Papanicolaou | 7 |
| Salk | 7 |
| Pseudomonas | 7 |
| Schleimhäuten | 7 |
| Thomas | 7 |
| Wirtszelle | 7 |
| Wahl | 7 |
| WNV | 7 |
| Vordergrund | 7 |
| Vevea | 7 |
| Verbesserung | 7 |
| Unit | 7 |
| Travel | 7 |
| Track | 7 |
| Tool | 7 |
| Vermeidung | 7 |
| Theory | 7 |
| Singh | 7 |
| Senator | 7 |
| Theatre | 7 |
| Sepsis | 7 |
| Sikkink | 7 |
| Xu | 7 |
| Snyder | 7 |
| Sudan | 7 |
| TCR | 7 |
| Marshall | 6 |
| Lohse | 6 |
| Lanzavecchia | 6 |
| Latino | 6 |
| Lebensjahr | 6 |
| Leber | 6 |
| Margaret | 6 |
| Lymphome | 6 |
| Lung | 6 |
| Langmuir | 6 |
| MR | 6 |
| Madagascar | 6 |
| Malawi | 6 |
| Manifestation | 6 |
| Man | 6 |
| Immunsupprimierter | 6 |
| LAV | 6 |
| History | 6 |
| Ho | 6 |
| Michigan | 6 |
| Hoffer | 6 |
| Holbrooke | 6 |
| IDSA | 6 |
| IDUQOL | 6 |
| Infektionskrankheit | 6 |
| Kontrolle | 6 |
| Initiatives | 6 |
| Jesse | 6 |
| Kaiser | 6 |
| Klatzmann | 6 |
| Klebsiella | 6 |
| Konjugat | 6 |
| Materialien | 6 |
| Pathogenesis | 6 |
| Microbial | 6 |
| PAH | 6 |
| Post | 6 |
| Helgeson | 6 |
| Populations | 6 |
| Poor | 6 |
| Polymerase | 6 |
| Planning | 6 |
| Pilzinfektionen | 6 |
| Peru | 6 |
| Personal | 6 |
| Pentoxifylline | 6 |
| Patel | 6 |
| Pasteur | 6 |
| Papillomaviren | 6 |
| Panthera | 6 |
| Outreach | 6 |
| Mid | 6 |
| Outcomes | 6 |
| Oral | 6 |
| Obama | 6 |
| OC | 6 |
| Norms | 6 |
| Needle | 6 |
| Natural | 6 |
| NIEO | 6 |
| NCAIDS | 6 |
| Mutationen | 6 |
| Monaten | 6 |
| Molecular | 6 |
| Mit | 6 |
| Miller | 6 |
| Hinweise | 6 |
| Aus | 6 |
| H1N1 | 6 |
| Booz | 6 |
| BMI | 6 |
| Bacillus | 6 |
| Baleanu | 6 |
| Bayer | 6 |
| Benson | 6 |
| Bestimmung | 6 |
| Britain | 6 |
| Guinea | 6 |
| CPC | 6 |
| CRS | 6 |
| Campaign | 6 |
| Chennai | 6 |
| Cipla | 6 |
| Class | 6 |
| Auffrischimpfungen | 6 |
| Asians | 6 |
| Argentina | 6 |
| Antigene | 6 |
| Antibody | 6 |
| Anteil | 6 |
| Ankara | 6 |
| Alle | 6 |
| Alexander | 6 |
| Al | 6 |
| Aktivierung | 6 |
| Aging | 6 |
| Age | 6 |
| Ad41 | 6 |
| Abstand | 6 |
| AWMF | 6 |
| Power | 6 |
| Co | 6 |
| Coccidioides | 6 |
| Comoros | 6 |
| Entwicklung | 6 |
| Good | 6 |
| Glucocorticoids | 6 |
| Geographic | 6 |
| Genom | 6 |
| Gag | 6 |
| Frau | 6 |
| Federal | 6 |
| Faktoren | 6 |
| FAO | 6 |
| Ethiopia | 6 |
| Enzyme | 6 |
| Enzephalopathie | 6 |
| Environmental | 6 |
| Environment | 6 |
| Encephalitozoon | 6 |
| Comparison | 6 |
| Emergence | 6 |
| Einteilung | 6 |
| Eindringen | 6 |
| EC | 6 |
| Dutch | 6 |
| Dis | 6 |
| Dentistry | 6 |
| Denial | 6 |
| Day | 6 |
| Dans | 6 |
| DR | 6 |
| Cyclospora | 6 |
| Cryptosporidia | 6 |
| Corynebacterium | 6 |
| Poverty | 6 |
| Summit | 6 |
| Practices | 6 |
| homosexuels | 6 |
| gehäuft | 6 |
| genetischen | 6 |
| gezielte | 6 |
| glomera | 6 |
| gp160 | 6 |
| gute | 6 |
| hyperimmune | 6 |
| national | 6 |
| insgesamt | 6 |
| interleukin-6 | 6 |
| jejuni | 6 |
| jiroveci | 6 |
| kein | 6 |
| lamina | 6 |
| geht | 6 |
| gebildet | 6 |
| extrapulmonary | 6 |
| einsetzbare | 6 |
| ebenso | 6 |
| ea | 6 |
| derzeit | 6 |
| corticotropin | 6 |
| cking | 6 |
| chloroquine | 6 |
| ces | 6 |
| cas | 6 |
| bronchopleural | 6 |
| biogroup | 6 |
| beträgt | 6 |
| b. | 6 |
| ausgeschlossen | 6 |
| las | 6 |
| nes | 6 |
| aspergillosis | 6 |
| wirken | 6 |
| ts | 6 |
| uns | 6 |
| unterschiedlich | 6 |
| verantwortlich | 6 |
| wenigen | 6 |
| weniger | 6 |
| zunehmende | 6 |
| nötig | 6 |
| zurück | 6 |
| ~f | 6 |
| ~nd | 6 |
| ~s | 6 |
| Presidential | 6 |
| ° | 6 |
| th~ | 6 |
| taux | 6 |
| survient | 6 |
| sulfadiazine | 6 |
| stellen | 6 |
| spezielle | 6 |
| sollten | 6 |
| socio | 6 |
| rotaviruses | 6 |
| rev | 6 |
| relativ | 6 |
| propria | 6 |
| primäre | 6 |
| posaconazole | 6 |
| plasmacytoid | 6 |
| penicillium | 6 |
| pH | 6 |
| atteinte | 6 |
| stula | 6 |
| aspergillar | 6 |
| Schutz | 6 |
| SPSS | 6 |
| STDs | 6 |
| STIs | 6 |
| SV40 | 6 |
| Sc | 6 |
| Schmerzen | 6 |
| Seattle | 6 |
| Staaten | 6 |
| Sector | 6 |
| Senegal | 6 |
| Serotypen | 6 |
| Situation | 6 |
| Smallpox | 6 |
| Spain | 6 |
| SPN | 6 |
| SIVmac | 6 |
| SIR | 6 |
| SCUC | 6 |
| SCID | 6 |
| Rotavirus | 6 |
| Rockefeller | 6 |
| Resistance | 6 |
| Representative | 6 |
| Reisen | 6 |
| Reference | 6 |
| Red | 6 |
| Q | 6 |
| Pu | 6 |
| Preventive | 6 |
| anderer | 6 |
| Primärinfektion | 6 |
| Speichel | 6 |
| Ribavirin | 6 |
| Stadien | 6 |
| Year | 6 |
| VP | 6 |
| Valacyclovir | 6 |
| Verminderung | 6 |
| Walker | 6 |
| Warren | 6 |
| Wisconsin | 6 |
| Yi | 6 |
| Tucker | 6 |
| Zealand | 6 |
| Ziehl | 6 |
| Ziel | 6 |
| Stadium | 6 |
| act | 6 |
| Zusammenhang | 6 |
| Unterscheidung | 6 |
| Yersinia | 6 |
| Transkriptase | 6 |
| Technical | 6 |
| Störungen | 6 |
| Tod | 6 |
| Standards | 6 |
| Survival | 6 |
| TSE | 6 |
| Tabelle | 6 |
| TSH | 6 |
| Texas | 6 |
| Therapeutisch | 6 |
| Therapiedauer | 6 |
| Tijuana | 6 |
| Jiabao | 5 |
| Klinische | 5 |
| Jintao | 5 |
| Jennifer | 5 |
| Johns | 5 |
| Justice | 5 |
| Kantian | 5 |
| Katheter | 5 |
| Jejunal | 5 |
| Keqiang | 5 |
| Latenz | 5 |
| Knowledge | 5 |
| Liver | 5 |
| Kopfschmerzen | 5 |
| Kriterien | 5 |
| Lage | 5 |
| Lechner | 5 |
| Legal | 5 |
| Lehmann | 5 |
| Leishmania | 5 |
| Iran | 5 |
| Lessons | 5 |
| Leukozyten | 5 |
| Jack | 5 |
| Häufig | 5 |
| Inzidenz | 5 |
| Hygiene | 5 |
| Hautveränderungen | 5 |
| Hemmer | 5 |
| Lues | 5 |
| Heute | 5 |
| Heymann | 5 |
| Hier | 5 |
| Holmes | 5 |
| Hopkins | 5 |
| Hp | 5 |
| Hurwitz | 5 |
| IBRD | 5 |
| Interventions | 5 |
| IR | 5 |
| Identification | 5 |
| Ig | 5 |
| IgE | 5 |
| Immundefekt | 5 |
| Improved | 5 |
| Indianapolis | 5 |
| Insurance | 5 |
| Interleukin-1 | 5 |
| Intervention | 5 |
| Luc | 5 |
| Nurses | 5 |
| Lymphadenopathie | 5 |
| PH | 5 |
| Nagelkerke | 5 |
| Nurse | 5 |
| O157 | 5 |
| OED | 5 |
| ORF | 5 |
| Open | 5 |
| Optimal | 5 |
| Organismus | 5 |
| P | 5 |
| PEG | 5 |
| PTH | 5 |
| NIE | 5 |
| PWID | 5 |
| Panel | 5 |
| Pathogenität | 5 |
| Petersburg | 5 |
| Physicians | 5 |
| Poland | 5 |
| Pontiac | 5 |
| Prime | 5 |
| Harris | 5 |
| Primärinfektionen | 5 |
| NY | 5 |
| NHIRD | 5 |
| Lymphknotenschwellungen | 5 |
| Mary | 5 |
| Läsionen | 5 |
| MCH | 5 |
| MERS | 5 |
| MVNP | 5 |
| Mal | 5 |
| Malay | 5 |
| Manifestationen | 5 |
| Mapping | 5 |
| Marseille | 5 |
| Martinez | 5 |
| Mauritius | 5 |
| NHI | 5 |
| McKeown | 5 |
| Medicines | 5 |
| Minnesota | 5 |
| Mission | 5 |
| Mittel | 5 |
| Monitoring | 5 |
| Multicenter | 5 |
| Multilateral | 5 |
| Mumps | 5 |
| NAAT | 5 |
| Hatch | 5 |
| Clin | 5 |
| Hanlon | 5 |
| Communist | 5 |
| Blastomyces | 5 |
| Bronchoscopy | 5 |
| CABG | 5 |
| Cambodia | 5 |
| Capacity | 5 |
| Carolina | 5 |
| Charter | 5 |
| Chez | 5 |
| Chief | 5 |
| Committees | 5 |
| Company | 5 |
| Bindung | 5 |
| Comprehensive | 5 |
| Coordinating | 5 |
| Crofelemer | 5 |
| Cryptosporidiosis | 5 |
| CtBP1 | 5 |
| Cueto | 5 |
| Cultural | 5 |
| DOT | 5 |
| Dauer | 5 |
| De | 5 |
| Bioethics | 5 |
| Bevölkerung | 5 |
| Halperin | 5 |
| Alert | 5 |
| Private | 5 |
| .05 | 5 |
| ADA | 5 |
| AIDs | 5 |
| AOR | 5 |
| AROC | 5 |
| Aamjiwnaang | 5 |
| Acyclovir | 5 |
| Africans | 5 |
| Agriculture | 5 |
| Alternative | 5 |
| Beteiligung | 5 |
| Andrew | 5 |
| Anfang | 5 |
| Ann | 5 |
| Antikörpern | 5 |
| Atangana | 5 |
| Ausmaß | 5 |
| BBC | 5 |
| BMC | 5 |
| Barcelona | 5 |
| Basic | 5 |
| Defense | 5 |
| Delhi | 5 |
| Demographic | 5 |
| Gore | 5 |
| Finnemore | 5 |
| Fluconazol | 5 |
| Fractional | 5 |
| GAO | 5 |
| GIS | 5 |
| Gastrointestinaltraktes | 5 |
| Gelbfieber | 5 |
| Geld | 5 |
| Genome | 5 |
| Gluckman | 5 |
| Groups | 5 |
| Detox | 5 |
| Guangxi | 5 |
| Guatemala | 5 |
| Guerin | 5 |
| Guillain | 5 |
| HAV | 5 |
| HEPATITIS | 5 |
| HHS | 5 |
| HIPC | 5 |
| HM | 5 |
| HRQOL | 5 |
| Famciclovir | 5 |
| FPE | 5 |
| FIP | 5 |
| Exposition | 5 |
| Dieser | 5 |
| Diphtherie | 5 |
| Division | 5 |
| Donald | 5 |
| Donnelly | 5 |
| E1A | 5 |
| ED | 5 |
| EIA | 5 |
| EISO | 5 |
| EU | 5 |
| Economist | 5 |
| Eden | 5 |
| Effekt | 5 |
| Einfluss | 5 |
| Einige | 5 |
| Enterprise | 5 |
| Epidemics | 5 |
| Ergebnisse | 5 |
| Estes | 5 |
| Europa | 5 |
| Experience | 5 |
| Prinzip | 5 |
| betreffen | 5 |
| Probleme | 5 |
| kB | 5 |
| hepatosplenomegaly | 5 |
| hoch | 5 |
| hohe | 5 |
| hvmg | 5 |
| häufigsten | 5 |
| ia | 5 |
| indiziert | 5 |
| insbesondere | 5 |
| intralobular | 5 |
| intrazelluläre | 5 |
| ketoconazole | 5 |
| gr | 5 |
| key | 5 |
| lavage | 5 |
| leo | 5 |
| liegen | 5 |
| lobular | 5 |
| mais | 5 |
| mehreren | 5 |
| microsporidiosis | 5 |
| mindestens | 5 |
| nehmen | 5 |
| hatten | 5 |
| geringer | 5 |
| nevirapine | 5 |
| diss6min6e | 5 |
| besonders | 5 |
| bestehen | 5 |
| bestimmten | 5 |
| betroffen | 5 |
| brin | 5 |
| clindamycin | 5 |
| dagegen | 5 |
| del | 5 |
| diesem | 5 |
| diskutiert | 5 |
| doch | 5 |
| genetisch | 5 |
| effektiv | 5 |
| entfernt | 5 |
| entwickelt | 5 |
| environ | 5 |
| erster | 5 |
| exudative | 5 |
| folgenden | 5 |
| forme | 5 |
| früher | 5 |
| frühzeitig | 5 |
| neue | 5 |
| ngertip | 5 |
| ausreichend | 5 |
| wirksam | 5 |
| tion | 5 |
| trans | 5 |
| trimetrexate | 5 |
| tritt | 5 |
| unspezifischen | 5 |
| v. | 5 |
| valganciclovir | 5 |
| vorhanden | 5 |
| weil | 5 |
| weiter | 5 |
| wobei | 5 |
| systemischen | 5 |
| zellulären | 5 |
| zwar | 5 |
| ähnlich | 5 |
| übertragen | 5 |
| γ | 5 |
| − | 5 |
| ∞ | 5 |
| ≤ | 5 |
| ␥ | 5 |
| Professor | 5 |
| tal | 5 |
| systemisch | 5 |
| ning | 5 |
| raschen | 5 |
| nombre | 5 |
| nvCJD | 5 |
| om | 5 |
| opportunistischen | 5 |
| pathog | 5 |
| peripheren | 5 |
| persistierende | 5 |
| peuvent | 5 |
| poveny | 5 |
| pp | 5 |
| rement | 5 |
| sur | 5 |
| responsable | 5 |
| ritonavir | 5 |
| rmed | 5 |
| seltene | 5 |
| seltener | 5 |
| ser | 5 |
| soit | 5 |
| solche | 5 |
| st | 5 |
| stark | 5 |
| beide | 5 |
| typischen | 5 |
| atovaquone | 5 |
| Sichuan | 5 |
| Seit | 5 |
| Selected | 5 |
| Self | 5 |
| Selgelid | 5 |
| Semmelweiss | 5 |
| Serologie | 5 |
| Serovare | 5 |
| Serum | 5 |
| Session | 5 |
| Seychelles | 5 |
| Siliciano | 5 |
| Secretariat | 5 |
| Simpson | 5 |
| Situationen | 5 |
| Spread | 5 |
| Staphylokokken | 5 |
| Statistics | 5 |
| Stigma | 5 |
| Stämme | 5 |
| Support | 5 |
| Susan | 5 |
| Symptomen | 5 |
| Sect | 5 |
| Screening | 5 |
| TDF | 5 |
| Retinitis | 5 |
| RBM | 5 |
| association | 5 |
| RCTs | 5 |
| RSV | 5 |
| Rand | 5 |
| Randomized | 5 |
| Reaktionen | 5 |
| Reaktivierungen | 5 |
| Regulation | 5 |
| Resident | 5 |
| Rev | 5 |
| Scientific | 5 |
| Rickettsia | 5 |
| Rift | 5 |
| River | 5 |
| Rome | 5 |
| Roubaty | 5 |
| Routh | 5 |
| S4 | 5 |
| SA | 5 |
| SDG | 5 |
| SDGs | 5 |
| T8 | 5 |
| Resources | 5 |
| TMP/ | 5 |
| Yuhki | 5 |
| Virusinfektionen | 5 |
| WA | 5 |
| WB | 5 |
| Waxman | 5 |
| Weekly | 5 |
| Wenn | 5 |
| WfCHR | 5 |
| Wong | 5 |
| Work | 5 |
| Wuhan | 5 |
| Z | 5 |
| Verletzung | 5 |
| Zeitpunkt | 5 |
| Zidovudine | 5 |
| Zoster | 5 |
| Zustand | 5 |
| airways | 5 |
| aktiven | 5 |
| antibakteriellen | 5 |
| an~ | 5 |
| Task | 5 |
| antigen | 5 |
| Verläufe | 5 |
| agent | 5 |
| Van | 5 |
| Trial | 5 |
| Theme | 5 |
| Theorem | 5 |
| VIH | 5 |
| Tetanus | 5 |
| Therapeutika | 5 |
| Tieren | 5 |
| Titanic | 5 |
| Titer | 5 |
| Tode | 5 |
| Transaminasen | 5 |
| Thoracic | 5 |
| Triomune | 5 |
| VACS | 5 |
| V520 | 5 |
| Urin | 5 |
| Typhus | 5 |
| V | 5 |
| Twenty | 5 |
| Tumoren | 5 |
| Tubercle | 5 |
| Trust | 5 |
| Ist | 4 |
| Karin | 4 |
| KBR | 4 |
| Joshua | 4 |
| Je | 4 |
| Jackson | 4 |
| Kathmandu | 4 |
| Inkubationszeiten | 4 |
| Islands | 4 |
| Intravenous | 4 |
| Internal | 4 |
| Indian | 4 |
| Injection | 4 |
| Impfstoffe | 4 |
| Informed | 4 |
| Induktion | 4 |
| Kofi | 4 |
| Induction | 4 |
| Kenntnis | 4 |
| Leadership | 4 |
| Konner | 4 |
| Libya | 4 |
| Louis | 4 |
| Loss | 4 |
| Immunsystem | 4 |
| Long | 4 |
| Litigation | 4 |
| Literature | 4 |
| Liouville | 4 |
| Lima | 4 |
| Leukopenie | 4 |
| Krankheitsbilder | 4 |
| Leffler | 4 |
| Lebensmonat | 4 |
| Latinos | 4 |
| Land | 4 |
| Labor | 4 |
| LFA | 4 |
| LAC | 4 |
| Kuru | 4 |
| Impfschutz | 4 |
| Helferzellen | 4 |
| Immunschwäche | 4 |
| Gubler | 4 |
| Hedges | 4 |
| Heart | 4 |
| Head | 4 |
| Hayhoe | 4 |
| HSV-1 | 4 |
| HHV-7 | 4 |
| HE | 4 |
| HDV | 4 |
| Gruskin | 4 |
| Immunology | 4 |
| Großbritannien | 4 |
| Gregory | 4 |
| Granulozyten | 4 |
| Gostin | 4 |
| 4 | |
| Girls | 4 |
| MBP | 4 |
| Gewichtsabnahme | 4 |
| Heeney | 4 |
| Henry | 4 |
| Hierzu | 4 |
| Hilar | 4 |
| Immungesunden | 4 |
| Immunfluoreszenz | 4 |
| Immigrant | 4 |
| Ils | 4 |
| Illinois | 4 |
| Identity | 4 |
| IX | 4 |
| IL-1Ra | 4 |
| IE | 4 |
| Hussain | 4 |
| Huang | 4 |
| Horner | 4 |
| Home | 4 |
| Holton | 4 |
| Hiv-1 | 4 |
| Hinzu | 4 |
| Hill | 4 |
| Lymphomen | 4 |
| Oliveri | 4 |
| MDG | 4 |
| Organisation | 4 |
| POL | 4 |
| PM | 4 |
| PHS | 4 |
| PHEIC | 4 |
| PBT | 4 |
| PBS | 4 |
| PAS | 4 |
| Oyeyemi | 4 |
| Orenstein | 4 |
| MHU | 4 |
| Oregon | 4 |
| Operations | 4 |
| Ones | 4 |
| Omran | 4 |
| Old | 4 |
| Octreotide | 4 |
| Observed | 4 |
| Nun | 4 |
| PPP | 4 |
| Parker | 4 |
| Paromomycin | 4 |
| Partikel | 4 |
| Genotyp | 4 |
| Protein | 4 |
| Promed | 4 |
| Produktion | 4 |
| Preparedness | 4 |
| Practitioner | 4 |
| Posttraumatic | 4 |
| Postinfectious | 4 |
| Politik | 4 |
| Pharyngitis | 4 |
| Pfizer | 4 |
| Peril | 4 |
| Penicillinallergie | 4 |
| Pearson | 4 |
| Patricia | 4 |
| Patients | 4 |
| Pathogenitätsfaktoren | 4 |
| Nukleosidanalogon | 4 |
| Notice | 4 |
| Northern | 4 |
| Modelling | 4 |
| Mississippi | 4 |
| Mills | 4 |
| Millionen | 4 |
| Microbiology | 4 |
| Meist | 4 |
| Medline | 4 |
| Medley | 4 |
| Measurement | 4 |
| Maria | 4 |
| Maputo | 4 |
| Manila | 4 |
| Malays | 4 |
| Maintenance | 4 |
| Mahler | 4 |
| Ma | 4 |
| MOS | 4 |
| MMWR | 4 |
| Modeling | 4 |
| Monetary | 4 |
| Neugeborenen | 4 |
| Mononukleose | 4 |
| Nervensystems | 4 |
| Nationen | 4 |
| Nancy | 4 |
| Nachtschweiß | 4 |
| NWQ | 4 |
| NRs | 4 |
| NPHS | 4 |
| NIDs | 4 |
| NHRC | 4 |
| NHANES | 4 |
| N= | 4 |
| Myanmar | 4 |
| Museveni | 4 |
| Murray | 4 |
| Movement | 4 |
| Morrow | 4 |
| Monozyten | 4 |
| Geschichte | 4 |
| CES | 4 |
| Gene | 4 |
| Beth | 4 |
| Brief | 4 |
| Bono | 4 |
| Body | 4 |
| Biosecurity | 4 |
| Biomedical | 4 |
| Bilateral | 4 |
| Biek | 4 |
| Beurteilung | 4 |
| Besonderheit | 4 |
| Bauchschmerzen | 4 |
| Beschreibung | 4 |
| Benin | 4 |
| Ben | 4 |
| Beläge | 4 |
| Beirut | 4 |
| Beide | 4 |
| Behavior | 4 |
| Bedingungen | 4 |
| Bronchoalveolar | 4 |
| Brondani | 4 |
| Burnet | 4 |
| Burns | 4 |
| Cockburn | 4 |
| Clarithromycin | 4 |
| Cities | 4 |
| Chow | 4 |
| Chi | 4 |